Novel Treatment Sequence Speeds Up Breast Reconstruction Procedures in Patients With Breast CancerApril 17, 2024Breast Cancer
High TIL Levels Linked to Improved Prognosis in Early TNBC Even in Absence of ChemotherapyApril 17, 2024Breast Cancer
Ribociclib + Nonsteroidal Aromatase Inhibitor Improves Prognosis in HR+/HER2− Early BCApril 17, 2024Breast Cancer
De-Escalating Axillary Surgery Feasible in Breast Cancer with Sentinel-Node MetastasesApril 17, 2024Breast Cancer
Oncology PracticeIs Axillary Surgery in Early Breast Cancer on Its Way Out?April 16, 2024Breast CancerPatient & Survivor Care
Oncology PracticeHow Medicare Reimbursement Trends Could Affect Breast SurgeriesApril 15, 2024Practice ManagementBreast CancerMetastatic Breast CancerPatient & Survivor CareBusiness of Medicine
Oncology PracticeNo Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024Preventive CarePractice ManagementPatient & Survivor CareRenal Cell CarcinomaSarcoma & GISTNonmelanoma Skin CancerNeuro-oncology
Oncology PracticeDo Real-World Data Support Omitting Sentinel Lymph Node Biopsy in Early Stage Breast Cancer?April 15, 2024Breast Cancer
Oncology PracticeOncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Oncology PracticeCirculating Tumor DNA Predicts Early Treatment Response in Patients With HER2-Positive CancersApril 12, 2024Patient & Survivor CareBreast CancerGastrointestinal CancerCNS/Brain CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid Cancers
Oncology PracticeRepeat MCED Testing May ID Early-Stage and Unscreened CancersApril 10, 2024Preventive CareBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersGastrointestinal Cancer
Oncology PracticeImPrint Identifies Patients With Breast Cancer Likely to Respond to Neoadjuvant ImmunotherapyApril 10, 2024Breast CancerMetastatic Breast CancerPatient & Survivor Care
Oncology PracticeLess Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Oncology PracticeFDA Expands Enhertu Indication to HER2-Positive Solid TumorsApril 9, 2024Breast CancerPatient & Survivor CarePractice ManagementGastrointestinal CancerMetastatic Breast Cancer
Oncology PracticeDo Tumor-infiltrating Lymphocytes Predict Better Breast Cancer Outcomes?April 8, 2024Breast CancerPatient & Survivor CarePreventive Care
